Aigen Investment Management, LP Amicus Therapeutics, Inc. Transaction History

Aigen Investment Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$11.43 - $14.24 $137,548 - $171,364	12,034 New	12,034 $141,000
Q3 2023 Nov 13, 2023	BUY	$11.78 - $13.86 $373,367 - $439,292	31,695 New	31,695 $385,000
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $233,484 - $289,769	21,401 New	21,401 $237,000
Q2 2022 Aug 02, 2022	SELL	$6.23 - $11.12 $75,351 - $134,496	-12,095 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$7.89 - $12.48 $95,429 - $150,945	12,095 New	12,095 $115,000
Q2 2021 Aug 10, 2021	SELL	$8.71 - $10.72 $198,823 - $244,705	-22,827 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$9.2 - $23.86 $210,008 - $544,652	22,827 New	22,827 $226,000
Q1 2020 May 08, 2020	SELL	$6.63 - $11.16 $13 - $22	-2 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$7.48 - $10.75 $14 - $21	2 New	2 $0

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.